Pfizer Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 26	Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22

Sales

2,519.65

2,281.35

2,193.17

2,424.76

2,610.99

Operating profit

904.09

740.23

635.30

808.86

835.73

Interest

9.48

8.41

15.41

13.39

10.49

Gross profit

1,082.56

904.07

800.40

896.52

887.89

EPS (Rs)

157.91

167.78

120.51

136.38

133.89

Other income

187.95

172.25

180.51

101.05

62.65

Stock adjustment

-33.59

25.36

-11.82

56.48

-72.90

Raw material

309.51

272.34

335.80

345.27

354.29

Power and fuel

-

-

-

-

-

Employee expenses

367.97

371.33

347.80

331.68

403.67

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

971.67

872.09

886.09

882.47

1,090.20

Provisions made

-

-

-

-

-

Depreciation

57.73

60.79

62.28

105.51

115.00

Taxation

253.24

248.49

194.74

200.08

160.33

Net profit / loss

722.43

767.60

551.33

623.93

612.56

Extra ordinary item

-49.16

172.81

7.95

33.00

-

Prior year adjustments

-

-

-

-

-

Equity capital

45.75

45.75

45.75

45.75

45.75

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

35.88

32.45

28.97

33.36

32.01

GPM (%)

39.98

36.85

33.72

35.49

33.21

NPM (%)

26.68

31.28

23.23

24.70

22.91